Clinical variables, biochemical parameters and neuroimaging values of patients classified according to early haematoma growth
| Early haematoma growth | P value | ||
| No (N=465) | Yes (N=188) | ||
| Age, years | 71.5±11.6 | 70.2±12.5 | 0.200 |
| Women, % | 48.4 | 43 | 0.061 |
| Previous Rankin scale | 1(0, 1) | 0(0, 1) | 0.415 |
| Latency time, min | 237.2±207.4 | 223.5±212.2 | 0.49 |
| Wake-up stroke, % | 5.6 | 4.8 | 0.848 |
| Arterial hypertension, % | 70.5 | 70.7 | 0.919 |
| Diabetes, % | 21.9 | 21.8 | 0.931 |
| Smoking, % | 8.8 | 11.7 | 0.305 |
| Enolism, % | 13.5 | 18.6 | 0.115 |
| Hyperlipidaemia, % | 41.1 | 39.4 | 0.725 |
| Peripheral arterial disease, % | 4.5 | 6.4 | 0.328 |
| Atrial fibrillation, % | 16.6 | 36.2 | <0.0001 |
| Ischaemic heart disease, % | 9.2 | 12.2 | 0.254 |
| Heart failure, % | 2.4 | 5.9 | 0.032 |
| Previous antiaggregants, % | 17 | 12.8 | 0.194 |
| Previous anticoagulants, % | 11.6 | 38.3 | <0.0001 |
| Axillary temperature at admission, °C | 36.6±0.8 | 36.9±0.7 | 0.003 |
| Glucose, mg/dL | 141.3±49.2 | 136.8±46.7 | 0.297 |
| Glycosylated haemoglobin, % | 5.9±1.0 | 5.9±0.9 | 0.85 |
| Leucocytes, ×103/mL | 9.2±3.2 | 8.9±3.3 | 0.272 |
| Haemoglobin, g/dL | 13.6±4.7 | 13.1±3.3 | 0.319 |
| Platelets, ×103/mL | 212.1±71.7 | 209.8±80.6 | 0.422 |
| Fibrinogen, mg/d | 448.3±103.2 | 432.5±99.9 | 0.101 |
| LDL cholesterol, mg/dL | 108.9±34.6 | 112.5±36.9 | 0.354 |
| HDL cholesterol, mg/dL | 39.7±21.3 | 36.6±17.6 | 0.152 |
| Triglycerides, mg/dL | 104.3±51.9 | 104.6±48.2 | 0.947 |
| Sedimentation rate, mm | 30.5±22.8 | 24.9±19.7 | 0.004 |
| Leukoaraiosis, % | 57.8 | 85.1 | <0.0001 |
| Degree of leukoaraiosis | <0.0001 | ||
| Grade I, % | 68.6 | 31.4 | |
| Grade II, % | 62 | 38 | |
| Grade III, % | 46.8 | 53.2 | |
| Basal volume ICH, mL | 44.7±38.8 | 29.6±28.8 | <0.0001 |
| Location of the ICH | 0.018 | ||
| Lobar, % | 43.9 | 35.5 | |
| Deep, % | 56.1 | 66.5 | |
| Ventricular/subarachnoid contamination, % | 19.4 | 17.6 | 0.659 |
| NIHSS at admission | 14 [10, 19] | 13 [9, 17] | <0.0001 |
| Rankin scale at 3 months | 3 [1, 6] | 3 [2, 6] | 0.007 |
| Poor outcome at 3 months, % | 59.8 | 71.3 | 0.007 |
| Etiopathogenesis | <0.0001 | ||
| Hypertensive, % | 57.8 | 36.7 | |
| Amyloid, % | 14.4 | 4.3 | |
| Antiplatelet drugs/anticoagulants, % | 11.4 | 39.9 | |
| Indeterminate/others, % | 16.3 | 19.1 | |
HDL, High Density Lipoprotein; ICH, intracerebral haemorrhage; LDL, Low Density Lipoprotein; NIHSS, National Institute of Health Stroke Scale.